Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial

Published:2015-08 Issue:8 Volume:3 Page:595-604
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Haidar Ahmad,Legault Laurent,Matteau-Pelletier Laurence,Messier Virginie,Dallaire Maryse,Ladouceur Martin,Rabasa-Lhoret Rémi

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference23 articles.

1. Epidemiology of type 1 diabetes;Maahs;Endocrinol Metab Clin North Am,2010

2. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT);White;J Pediatr,2001

3. Findings from the Hvidore Study Group on Childhood Diabetes: metabolic control and quality of life;Mortensen;Horm Res,2002

4. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines;Wood;Diabetes Care,2013

5. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM;Davis;Diabetes Care,1997

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated insulin delivery in children with type 1 diabetes during physical activity: a meta-analysis;Journal of Pediatric Endocrinology and Metabolism;2024-05-03

2. Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-analysis of Outpatient Randomized Controlled Trials;Diabetes Care;2023-11-27

3. Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?;International Journal of Molecular Sciences;2023-08-24

4. Participant Experiences of Low-Dose Empagliflozin Use as Adjunct Therapy to Hybrid Closed Loop: Findings From a Randomized Controlled Trial;Journal of Diabetes Science and Technology;2023-05-25

5. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes;Diabetes Care;2023-05-03